Generic Drugs Key Tool For PBMs In Keeping Costs Down

Keep Reading

PCMA Statement on New Avalere Study Examining Generic Drugs in Medicare

(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement today on a new Avalere study, Generic Drugs in Medicare Part D, Trends in Tier Structure and Placement, released by the Association for Accessible Medicines: As the Avalere study points out, putting more expensive generics in non-preferred tiers helps keep premiums low....

Keep Reading

Updated Study: Proposed MAC Legislation May Increase Costs of Affected Generic Drugs By More Than 50 Percent

MAC (Maximum Allowable Cost) is a savings tool used by Medicare, Medicaid, large employers, and other health plans in order to prevent overpayments for generic prescriptions. A MAC is simply the maximum amount that a health plan will reimburse a pharmacy for a given strength and dosage form of a particular generic drug. A drugstore...

Keep Reading

Generic Drug Utilization

Keep Reading

Proposed MAC Legislation May Increase Costs Of Affected Generic Drugs By More Than 50 Percent

MAC (Maximum Allowable Cost) is a savings tool used by Medicare, Medicaid, large employers, and other health plans in order to prevent overpayments for generic prescriptions. A MAC is simply the maximum amount that a health plan will reimburse a pharmacy for a given strength and dosage form of a particular generic drug. A drugstore...

Keep Reading

New NCPA Report Highlights How Drug Wholesalers, Independent Drugstores Profit From Generic Price Hikes

(Washington D.C.)— A new report released by the National Center for Policy Analysis (NCPA) examining generic drug price increases finds that drug wholesaler price manipulation and the relationship these large Fortune 50 companies have with drugstores is hurting competition and increasing costs. The report also warns policymakers to avoid undermining proven payer tools, including the...

Keep Reading

Undermining Generic Drug Substitution: The Cost of Generic Carve-Out Legislation

Well-established laws in all 50 states permit a pharmacist to make a generic substitution unless otherwise directed by a prescriber. In fact, laws in fifteen states—including health care bellwethers such as Florida, Massachusetts, New York, and Tennessee—require that pharmacists substitute generics for brands unless the prescriber specifically orders the brand to be dispensed. Established laws also allow a prescriber...

Keep Reading

New Study Finds Generic Medications Saved $1 Trillion Over the Last Decade

The American health care system saved more than $1 trillion through the use of generic medicines over the last decade, according to a new study released by the Generic Pharmaceutical Association (GPhA). The analysis conducted by IMS Health highlights the value of generic medications and serves as a reminder of the powerful ways that pharmacy...

Keep Reading

Setting the Record Straight: Mail-Service Pharmacies Driving Generic Utilization

(Washington, DC) — The Pharmaceutical Care Management Association (PCMA) issued the following statement today on pharmacy benefit managers (PBMs) and mail-service pharmacies increasing the use of generic medications: “Proven PBM tools and techniques – including increasing the use of generic medications and lower cost mail-service pharmacies – have helped result in drug spending during the...

Keep Reading

Generic Drug Industry Honors PCMA President & CEO Mark Merritt with Prestigious ‘Outstanding Contribution’ Award

(Washington, DC) — The Generic Pharmaceutical Association (GPhA), which represents the world’s leading generic drug manufacturers and suppliers, has honored Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt with the industry’s prestigious “Outstanding Contribution” Award. The award was presented at GPhA’s Annual Meeting in Orlando, Florida. PCMA represents the nation’s PBMs which improve...

Keep Reading